Senior Director, Health Economics & Outcomes Research, Rare Disease Vyndaqel
Employment Type: Full-Time
Industry: Scientific Research
Loading some great jobs for you...
The SD HEOR will formulate HEOR strategy and coordinate HEOR colleague's evidence generation activities to support the value story and the optimal reimbursement and access for Vyndaqel. They will ensure the team is delivering robust evidence demonstrating the value that is aligned with overall access, commercial and clinical strategy and impact business objectives on a global scale. The SD HEOR is responsible for the overall quality, scientific and technical excellence of HEOR deliverables for assigned assets and will represent the PHI Vyndaqel team on key internal workstreams. The role will cover US, prioritized International Developed Markets (IDM) and Emerging Markets (EM) as needed.
The SD HEOR will function with a one-Patient and Health Impact (PHI) mindset and work in a closely aligned fashion with the full team to ensure there is a single and coordinated view on strategy and delivery from PHI to the business. The execution of this leadership position will require close collaboration with Global & local stakeholders. This position reports to the Integrated team Lead for Vyndaqel.ROLE RESPONSIBILITIES
- Leading HEOR strategy development to support asset strategies and product positioning in partnership with the global product / therapeutic area asset teams.
- Leading the RWE technical review committee for the Vyndaqel (and responsible for protocol technical sign off)
- Co- leading with Medical Affairs the RWE evidence and communication strategy
- Leading publication sign off as by PSC for the assigned assets
- Able to influence and shape the life cycle management program utilizing individual depth of knowledge and experience in value evidence generation & reimbursement.
- Lead the execution and alignment of HEOR studies and projects in accordance with the global HEOR strategy to support and enhance the value proposition for the assigned assets. May include some or all the following:
- Create and maintain global value dossiers, evidence blueprints, payer value messages and innovative tools
- Develop and utilize cost-effectiveness, budget impact, and health impact model(s) to communicate the public health and economic value of the asset(s)
- Conduct observational studies (e.g. burden of disease, outcomes research, costing studies, etc.) within non-interventional study processes
- Develop real world evidence generation strategies and execute studies (e.g. treatment patterns, real world effectiveness, burden of illness, costing, epidemiology studies, etc.) within non-interventional study processes
- Incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy & access targets for the asset(s)
- Generate peer-reviewed publications to communicate study findings in scientific channels in alignment with the product publication strategy
- Develop and validate new Patient Reported Outcomes measures, as appropriate, for inclusion across clinical trials, registries, and prospective real-world studies
- Lead the coordination of input from prioritized local country Health & Value teams on evidence needs and ensure that the input is appropriately incorporated to support global market access needs
- Support priority country Health & Value launch and post launch deliverables including adaptations of global tools such as value dossiers, evidence blueprints, economic models, and innovative tools to successfully support global launch and post-launch reimbursement and access requirements
- Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers
- Assess, synthesize, and interpret relevant literature and communicate findings to internal and external stakeholders
- Execute and manage research projects with external collaborators/vendors to ensure timely completion and quality of deliverables as well as budget/legal compliance
- Influence HEOR policies and methodological advances inside and outside the company by leading key cross-divisional task forces to help improve processes and standards in HEOR research programs.
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
- Masters (MSc, MPH) or Doctoral degree (PhD, Dr PH, ScD) in health services research, public health, epidemiology, or health economics
- Minimum of 10 years of experience in HEOR or relevant related fields
#LI-PFE Sunshine Act
- Previous HEOR team leadership
- Demonstrated expert understanding of fundamental health services research methods and tools including but not limited to:
- Health economics
- Cost-effectiveness / budgetary impact modeling
- Prospective and retrospective data analyses
- Patient reported outcomes measures
- Real world evidence studies
- Knowledge and experience in this and other therapeutic areas is preferred
- Able to independently engage all levels of stakeholders through a strong customer orientation, strategic thinking, leading change, and building collaborative partnerships in a matrix environment
- Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
- Experience with HTA organizations such as NICE, SMC, PBAC desirable
- Understanding of emerging Japan HTA methodology also desirable
- Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities in a compliant manner
- Excellent oral and written English communication skills are required
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. Last Date to Apply for Job: November 20, 2019
Eligible for Employee Referral Bonus
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
Associated topics: design, engineering, manufacture, product, product manager, production, program manager, quality
Loading some great jobs for you...